NO20015113L - New compounds, their preparation and use - Google Patents
New compounds, their preparation and useInfo
- Publication number
- NO20015113L NO20015113L NO20015113A NO20015113A NO20015113L NO 20015113 L NO20015113 L NO 20015113L NO 20015113 A NO20015113 A NO 20015113A NO 20015113 A NO20015113 A NO 20015113A NO 20015113 L NO20015113 L NO 20015113L
- Authority
- NO
- Norway
- Prior art keywords
- preparation
- new compounds
- compounds
- new
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
- C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
- C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D213/24—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D213/28—Radicals substituted by singly-bound oxygen or sulphur atoms
- C07D213/30—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P13/00—Drugs for disorders of the urinary system
- A61P13/12—Drugs for disorders of the urinary system of the kidneys
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/06—Antipsoriatics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
- A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/06—Antihyperlipidemics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C59/00—Compounds having carboxyl groups bound to acyclic carbon atoms and containing any of the groups OH, O—metal, —CHO, keto, ether, groups, groups, or groups
- C07C59/40—Unsaturated compounds
- C07C59/58—Unsaturated compounds containing ether groups, groups, groups, or groups
- C07C59/64—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings
- C07C59/66—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings
- C07C59/68—Unsaturated compounds containing ether groups, groups, groups, or groups containing six-membered aromatic rings the non-carboxylic part of the ether containing six-membered aromatic rings the oxygen atom of the ether group being bound to a non-condensed six-membered aromatic ring
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C69/00—Esters of carboxylic acids; Esters of carbonic or haloformic acids
- C07C69/66—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety
- C07C69/73—Esters of carboxylic acids having esterified carboxylic groups bound to acyclic carbon atoms and having any of the groups OH, O—metal, —CHO, keto, ether, acyloxy, groups, groups, or in the acid moiety of unsaturated acids
- C07C69/734—Ethers
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
- C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
- C07D307/34—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members
- C07D307/38—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having two or three double bonds between ring members or between ring members and non-ring members with substituted hydrocarbon radicals attached to ring carbon atoms
- C07D307/40—Radicals substituted by oxygen atoms
- C07D307/42—Singly bound oxygen atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/06—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to the ring carbon atoms
- C07D333/14—Radicals substituted by singly bound hetero atoms other than halogen
- C07D333/16—Radicals substituted by singly bound hetero atoms other than halogen by oxygen atoms
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmacology & Pharmacy (AREA)
- General Health & Medical Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Hematology (AREA)
- Physical Education & Sports Medicine (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Rheumatology (AREA)
- Child & Adolescent Psychology (AREA)
- Endocrinology (AREA)
- Dermatology (AREA)
- Emergency Medicine (AREA)
- Hospice & Palliative Care (AREA)
- Psychiatry (AREA)
- Urology & Nephrology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Pyridine Compounds (AREA)
- Heterocyclic Compounds Containing Sulfur Atoms (AREA)
- Furan Compounds (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
DKPA199900533 | 1999-04-20 | ||
PCT/DK2000/000190 WO2000063153A1 (en) | 1999-04-20 | 2000-04-17 | New compounds, their preparation and use |
Publications (2)
Publication Number | Publication Date |
---|---|
NO20015113D0 NO20015113D0 (en) | 2001-10-19 |
NO20015113L true NO20015113L (en) | 2001-12-19 |
Family
ID=8094620
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
NO20015113A NO20015113L (en) | 1999-04-20 | 2001-10-19 | New compounds, their preparation and use |
Country Status (16)
Country | Link |
---|---|
EP (1) | EP1171414A1 (en) |
JP (1) | JP2002542218A (en) |
KR (1) | KR20020005703A (en) |
CN (1) | CN1348439A (en) |
AU (1) | AU3958000A (en) |
BR (1) | BR0009864A (en) |
CA (1) | CA2367356A1 (en) |
CZ (1) | CZ20013558A3 (en) |
HU (1) | HUP0200807A3 (en) |
IL (1) | IL145789A0 (en) |
NO (1) | NO20015113L (en) |
PL (1) | PL351312A1 (en) |
RU (1) | RU2001131111A (en) |
TW (1) | TW553931B (en) |
WO (1) | WO2000063153A1 (en) |
ZA (1) | ZA200107983B (en) |
Families Citing this family (59)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US6555577B1 (en) | 2000-01-28 | 2003-04-29 | Novo Nordisk A/S | Compounds, their preparation and use |
CA2395298A1 (en) * | 2000-01-28 | 2001-08-02 | Novo Nordisk A/S | Propionic acid derivatives and their use in the treatment of diabetes and obesity |
JP2003525908A (en) | 2000-03-08 | 2003-09-02 | ノボ ノルディスク アクティーゼルスカブ | Low serum lipids |
EP1911462A3 (en) | 2001-01-26 | 2011-11-30 | Schering Corporation | Compositions comprising a sterol absorption inhibitor |
WO2003011834A1 (en) * | 2001-07-30 | 2003-02-13 | Novo Nordisk A/S | Novel vinyl n-(2-benzoylphenyl)-l-tyrosine derivatives and their use as antidiabetics etc |
US7067530B2 (en) | 2001-07-30 | 2006-06-27 | Novo Nordisk A/S | Compounds, their preparation and use |
US6869967B2 (en) | 2001-07-30 | 2005-03-22 | Novo Nordisk A/S | Peroxisome proliferator-activated receptor (PPAR) active vinyl carboxylic acid derivatives |
JP2004536152A (en) * | 2001-07-30 | 2004-12-02 | ノボ ノルディスク アクティーゼルスカブ | Novel vinyl N- (2-benzoylphenyl) -L-tyrosine derivatives and their use for antidiabetic agents and the like |
CN1537093A (en) * | 2001-07-30 | 2004-10-13 | ŵ��Ų�ڿ˹�˾ | Novel vinyl carboxylic acid derivatives and their use as antidiabetics etc. |
EP2243776A1 (en) | 2001-10-12 | 2010-10-27 | High Point Pharmaceuticals, LLC | Substituted piperidines and their use for the treatment of diseases related to the histamine H3 receptor |
JP2005518391A (en) | 2001-12-21 | 2005-06-23 | ノボ ノルディスク アクティーゼルスカブ | Amide derivatives as GK activators |
US7015345B2 (en) | 2002-02-21 | 2006-03-21 | Asahi Kasei Pharma Corporation | Propionic acid derivatives |
US6716842B2 (en) | 2002-04-05 | 2004-04-06 | Warner-Lambert Company, Llc | Antidiabetic agents |
JP4881559B2 (en) | 2002-06-27 | 2012-02-22 | ノボ・ノルデイスク・エー/エス | Arylcarbonyl derivatives as therapeutic agents |
CN1688540A (en) | 2002-09-05 | 2005-10-26 | 诺沃挪第克公司 | Novel vinyl carboxylic acid derivatives and their therapeutical use |
KR20050055790A (en) * | 2002-10-28 | 2005-06-13 | 노보 노르디스크 에이/에스 | Novel compounds useful in treating ppar mediated diseases |
US7129268B2 (en) * | 2002-10-28 | 2006-10-31 | Novo Nordisk A/S | Peroxisome proliferator activated receptor-active arylene acetic acid derivatives |
CN100491316C (en) | 2002-10-28 | 2009-05-27 | 高点制药有限责任公司 | Novel compounds, their preparation and use |
PL376718A1 (en) * | 2002-10-28 | 2006-01-09 | Novo Nordisk A/S | Novel compounds, their preparation and use |
US7816385B2 (en) | 2002-12-20 | 2010-10-19 | High Point Pharmaceuticals, Llc | Dimeric dicarboxylic acid derivatives, their preparation and use |
JP2006510687A (en) * | 2002-12-20 | 2006-03-30 | ノボ ノルディスク アクティーゼルスカブ | Novel compounds, their preparation and use |
DE602004022153D1 (en) | 2003-05-14 | 2009-09-03 | High Point Pharmaceuticals Llc | COMPOUNDS FOR THE TREATMENT OF OBESITAS |
JP4928941B2 (en) | 2003-09-19 | 2012-05-09 | ジヤンセン・フアーマシユーチカ・ナームローゼ・フエンノートシヤツプ | 4-((phenoxyalkyl) thio) -phenoxyacetic acid and similar compounds |
BRPI0414890A (en) | 2003-09-30 | 2006-12-12 | Novo Nordisk As | compound, methods of retarding the progression of igt to type 2 diabetes, and type 2 diabetes to insulin-requiring diabetes, to treat obesity or prevent overweight, to regulate appetite, to induce satiety, to prevent weight gain. weight, increasing energy expenditure, and treating a disease or condition, pharmaceutical composition, and use of a compound |
JP4865565B2 (en) | 2003-12-09 | 2012-02-01 | ノヴォ ノルディスク アー/エス | Controlling food selection using GLP-1 agonists |
EP2444397A1 (en) | 2004-01-06 | 2012-04-25 | Novo Nordisk A/S | Heteroaryl-ureas and their use as glucokinase activators |
JP2007536344A (en) | 2004-05-04 | 2007-12-13 | ノボ ノルディスク アクティーゼルスカブ | New indole derivatives |
ES2353391T3 (en) * | 2004-05-05 | 2011-03-01 | High Point Pharmaceuticals, Llc | NEW COMPOUNDS, THEIR PREPARATION AND USE. |
WO2005105736A1 (en) * | 2004-05-05 | 2005-11-10 | Novo Nordisk A/S | Novel compounds, their preparation and use |
WO2005120492A1 (en) | 2004-06-11 | 2005-12-22 | Novo Nordisk A/S | Counteracting drug-induced obesity using glp-1 agonists |
CN101060856B (en) | 2004-11-22 | 2011-01-19 | 诺和诺德公司 | Soluble, stable insulin-containing formulations with a protamine salt |
EP1824835A1 (en) | 2004-12-03 | 2007-08-29 | Novo Nordisk A/S | Heteroaromatic glucokinase activators |
FR2882359A1 (en) * | 2005-02-24 | 2006-08-25 | Negma Lerads Soc Par Actions S | New phenyl compounds are peroxisome proliferator activated receptor activators useful to treat hyperlipidemia and atherosclerosis |
CA2599281C (en) * | 2005-02-25 | 2012-01-17 | Heonjoong Kang | Thiazole derivatives as ppar delta ligands and their manufacturing process |
ES2375929T3 (en) | 2005-07-04 | 2012-03-07 | High Point Pharmaceuticals, Llc | HISTAMINE RECEIVER ANTAGONISTS H3. |
ES2422383T3 (en) | 2005-07-14 | 2013-09-11 | Novo Nordisk As | Urea glucokinase activators |
ES2426345T3 (en) | 2005-07-20 | 2013-10-22 | Eli Lilly And Company | Compound bound in 1-amino position |
JP5198280B2 (en) | 2005-11-17 | 2013-05-15 | イーライ リリー アンド カンパニー | Glucagon receptor antagonists and their preparation and therapeutic use |
US7943613B2 (en) | 2005-12-22 | 2011-05-17 | High Point Pharmaceuticals, Llc | Compounds, their preparation and use |
CN101410385B (en) | 2006-03-28 | 2011-08-24 | 高点制药有限责任公司 | Benzothiazoles having histamine H3 receptor activity |
SG163547A1 (en) | 2006-05-29 | 2010-08-30 | High Point Pharmaceuticals Llc | 3- (1, 3-benz0di0x0l-5-yl) -6- (4-cyclopropylpiperazin-1-yl) -pyridazine, its salts and solvates and its use as histamine h3 receptor antagonist |
WO2008059026A1 (en) | 2006-11-15 | 2008-05-22 | High Point Pharmaceuticals, Llc | Novel 2-(2-hydroxyphenyl)benzimidazoles useful for treating obesity and diabetes |
ATE538109T1 (en) | 2006-11-15 | 2012-01-15 | High Point Pharmaceuticals Llc | NEW 2-(2-HYDROXYPHENYL)BENZOTHIADIAZINE SUITABLE FOR THE TREATMENT OF OBESITY AND DIABETES |
JP5226008B2 (en) | 2007-01-11 | 2013-07-03 | ノボ・ノルデイスク・エー/エス | Urea glucokinase activator |
US20130012432A1 (en) | 2010-02-26 | 2013-01-10 | Novo Nordisk A/S | Peptides for Treatment of Obesity |
BR112012021231A2 (en) | 2010-02-26 | 2015-09-08 | Basf Plant Science Co Gmbh | method for enhancing plant yield, plant, construct, use of a construct, method for producing a transgenic plant, collectable parts of a plant, products derived from a plant, use of a nucleic acid and method for producing a product |
JP6054861B2 (en) | 2010-03-26 | 2016-12-27 | ノヴォ ノルディスク アー/エス | New glucagon analogues |
WO2012027331A1 (en) | 2010-08-27 | 2012-03-01 | Ironwood Pharmaceuticals, Inc. | Compositions and methods for treating or preventing metabolic syndrome and related diseases and disorders |
WO2012104834A1 (en) | 2011-02-03 | 2012-08-09 | Pharmedica Ltd. | New oral dissolving films for insulin administration, for treating diabetes |
MX2013011175A (en) | 2011-03-28 | 2013-11-01 | Novo Nordisk As | Novel glucagon analogues. |
BR112014006684A2 (en) | 2011-09-23 | 2017-03-28 | Novo Nordisk As | glucagon analogs |
BR112015025464A2 (en) | 2013-04-18 | 2017-10-10 | Novo Nordisk As | stable, prolonged glp-1 / glucagon receptor coagonists for medical use |
US10570184B2 (en) | 2014-06-04 | 2020-02-25 | Novo Nordisk A/S | GLP-1/glucagon receptor co-agonists for medical use |
CN107915701B (en) * | 2016-10-10 | 2020-09-29 | 沈阳药科大学 | PPAR alpha/gamma dual agonist and application thereof |
CN111032680A (en) | 2017-03-15 | 2020-04-17 | 诺和诺德股份有限公司 | Bicyclic compounds capable of binding to melanocortin 4 receptor |
WO2019219714A1 (en) | 2018-05-15 | 2019-11-21 | Novo Nordisk A/S | Compounds capable of binding to melanocortin 4 receptor |
WO2020053414A1 (en) | 2018-09-14 | 2020-03-19 | Novo Nordisk A/S | Bicyclic compounds capable of acting as melanocortin 4 receptor agonists |
KR20230054373A (en) | 2020-07-22 | 2023-04-24 | 르네오 파마슈티컬스, 인크. | Crystalline PPAR-delta agonists |
WO2023147309A1 (en) | 2022-01-25 | 2023-08-03 | Reneo Pharmaceuticals, Inc. | Use of ppar-delta agonists in the treatment of disease |
Family Cites Families (9)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
BR9508468A (en) * | 1994-07-29 | 1997-11-25 | Smithkline Beecham Plc | Compound process for the preparation of the same pharmaceutical composition processes for the treatment and / or prophylaxis of hyperglycemia in a human or non-human mammal and for the treatment of hyperlipidemia hypertension cardiovascular disease some eating disorders the treatment and / or prophylaxis of kidney disease prevention revers o stabilization or retardation of microalbuminuria progression in a human or non-human mammal use of the compound and intermediate compound |
GB9600464D0 (en) * | 1996-01-09 | 1996-03-13 | Smithkline Beecham Plc | Novel method |
GB9604242D0 (en) * | 1996-02-28 | 1996-05-01 | Glaxo Wellcome Inc | Chemical compounds |
DE69815008T2 (en) * | 1997-09-19 | 2004-04-01 | Ssp Co., Ltd. | Alpha-substituted phenylpropionic acid derivatives and medicaments containing them |
WO1999019313A1 (en) * | 1997-10-27 | 1999-04-22 | Dr. Reddy's Research Foundation | Novel tricyclic compounds and their use in medicine; process for their preparation and pharmaceutical compositions containing them |
CN1280574A (en) * | 1997-10-27 | 2001-01-17 | 雷迪研究基金会 | New heterocyclic compounds and their use in medicine, process for their prepartion and pharmaceutical compositions containing them |
AU1887999A (en) * | 1998-01-29 | 1999-08-16 | Dr. Reddy's Research Foundation | Novel alkanoic acids and their use in medicine, process for their preparation and pharmaceutical compositions containing them |
DE69828445D1 (en) * | 1998-04-23 | 2005-02-03 | Reddys Lab Ltd Dr | HETEROCYCLIC COMPOUNDS, AND THEIR USE IN MEDICAMENTS, PROCESS FOR THE PREPARATION THEREOF AND PHARMACEUTICAL COMPOSITIONS CONTAINING THEREOF |
NZ504106A (en) * | 1998-05-27 | 2003-02-28 | Dr | Fused Oxazine, Thiazine and pipyridine compounds, process for their preparation and pharmaceutical compositions containing them |
-
2000
- 2000-04-17 JP JP2000612250A patent/JP2002542218A/en active Pending
- 2000-04-17 WO PCT/DK2000/000190 patent/WO2000063153A1/en not_active Application Discontinuation
- 2000-04-17 KR KR1020017013417A patent/KR20020005703A/en not_active Application Discontinuation
- 2000-04-17 EP EP00918725A patent/EP1171414A1/en not_active Withdrawn
- 2000-04-17 IL IL14578900A patent/IL145789A0/en unknown
- 2000-04-17 CN CN00806561A patent/CN1348439A/en active Pending
- 2000-04-17 AU AU39580/00A patent/AU3958000A/en not_active Abandoned
- 2000-04-17 PL PL00351312A patent/PL351312A1/en not_active Application Discontinuation
- 2000-04-17 RU RU2001131111/04A patent/RU2001131111A/en not_active Application Discontinuation
- 2000-04-17 HU HU0200807A patent/HUP0200807A3/en unknown
- 2000-04-17 BR BR0009864-7A patent/BR0009864A/en not_active IP Right Cessation
- 2000-04-17 CZ CZ20013558A patent/CZ20013558A3/en unknown
- 2000-04-17 CA CA002367356A patent/CA2367356A1/en not_active Abandoned
- 2000-05-02 TW TW089108460A patent/TW553931B/en not_active IP Right Cessation
-
2001
- 2001-09-28 ZA ZA200107983A patent/ZA200107983B/en unknown
- 2001-10-19 NO NO20015113A patent/NO20015113L/en not_active Application Discontinuation
Also Published As
Publication number | Publication date |
---|---|
EP1171414A1 (en) | 2002-01-16 |
PL351312A1 (en) | 2003-04-07 |
BR0009864A (en) | 2002-01-08 |
RU2001131111A (en) | 2003-08-10 |
JP2002542218A (en) | 2002-12-10 |
ZA200107983B (en) | 2002-05-29 |
HUP0200807A2 (en) | 2002-07-29 |
AU3958000A (en) | 2000-11-02 |
NO20015113D0 (en) | 2001-10-19 |
KR20020005703A (en) | 2002-01-17 |
TW553931B (en) | 2003-09-21 |
CN1348439A (en) | 2002-05-08 |
WO2000063153A1 (en) | 2000-10-26 |
CZ20013558A3 (en) | 2002-05-15 |
IL145789A0 (en) | 2002-07-25 |
CA2367356A1 (en) | 2000-10-26 |
HUP0200807A3 (en) | 2003-03-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
NO20015113D0 (en) | New compounds, their preparation and use | |
NO20015156L (en) | 5-pyridyl-1,3-azole compounds, their preparation and use | |
NO20014603L (en) | Tienopyrimidine Compounds, Their Preparation and Use | |
NO20021449L (en) | Substituted 2-thio-3,5-dicyano-4-aryl-6-aminopyridines and their use | |
NO20024742L (en) | Heterocyclic compounds, their preparation and use | |
NO20014135L (en) | New sulfonamide compounds and their use | |
NO20012567D0 (en) | Azepinoindole derivatives, preparation and use thereof | |
NO20015362L (en) | Heterocyclic substituted benzimidazoles, their preparation and use thereof | |
NO20005266D0 (en) | Novel substituted amides, their preparation and use | |
DK1073672T3 (en) | Antipicornaviral compounds, their preparation and use | |
NO20005146L (en) | Thienylazolylalkoxyethanamines, their preparation and their use as drugs | |
DK1161434T3 (en) | Pyridopyranoazepine derivatives, their preparation and therapeutic use | |
NO20031838D0 (en) | Benzocazine derivatives, their preparation and use | |
NO20023146L (en) | Substituted phenyl-piperazine derivatives, their preparation and use | |
NO20052124D0 (en) | New 1,4-diazabicycloalkane derivatives, their preparation and use | |
NO20032234D0 (en) | Novel imidazole derivatives, their preparation and use | |
DK1043307T3 (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use | |
NO20020156D0 (en) | Titanium derived compounds, their preparation and their use | |
NO20006479D0 (en) | Tienopyridine compounds, their preparation and use | |
NO20024107L (en) | Tienopyridine derivatives, their preparation and use | |
NO20025209L (en) | Cyclipostins, their preparation and use | |
NO20023188L (en) | New heteroaryl derivatives, their preparation and use | |
NO20001782D0 (en) | 3-Amino-3-arylpropan-1-ol derivatives, their preparation and use | |
NO996156L (en) | Substituted cycloheptans, their preparation and use | |
NO20020404D0 (en) | Streptogramin derivatives, their production and compounds thereof |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FC2A | Withdrawal, rejection or dismissal of laid open patent application |